Alkalinizing Agents for Kidney Stones

"This medical experiment is searching for participants aged 18 or above, and no older than 90 years old."

"Crystal Lite is primarily prescribed to treat nephrolithiasis, a disease caused by calcium oxalate. It has also been used to combat barbiturate addiction, helicobacter infections, and acute diarrhea."

"The enrolment criteria for this clinical trial necessitates that applicants possess a history of kidney stones and are between 18 to 90 years old. Fifteen individuals will be accepted into the study."

"This medical trial will primarily assess the change in 24-hour urine uric acid from baseline to the end of study (Day 12). Secondary objectives involve collecting data from a Patient Satisfaction Survey, measuring patient adherence to medication throughout the duration of the study, and assessing overall satisfaction with an 18 question Patients Satisfaction Questionnaire Short Form. Scores range between 18-90, where higher scores indicate greater levels of contentment."

"Affirmative, according to the information on clinicaltrials.gov this medical experiment is actively seeking participants despite being uploaded as early as March 16th 2021 and its most recent update occurring June 30th 2022. 15 persons from a single site must be enrolled in order for the trial to commence."

"Current information hosted on clinicaltrials.gov indicates that this trial is presently recruiting participants. It was initially announced on March 16th 2021 and the most recent update occured June 30th 2022."

"Currently, 27 clinical trials for Crystal Lite are ongoing with 2 in Phase 3. Decatur, Georgia is home to several of these studies and a total of 42 sites are running tests on this medication globally."